IINN - רווח נקי למניה (EPS TTM) Inspira Technologies Oxy B.H.N. Ltd

Inspira Technologies Oxy (IINN) is strengthening its position by implementing blood oxygenation systems in collaboration with medtech manufacturers. The profit per unit trend over the last 12 months confirms this influence, with the indicator holding around -0.45. However, the Israeli business is exposed to geopolitical risks and chip sanctions, while the absence of FDA and CE certifications blocks the commercial launch of the blood purification ecosystem.
IINN (Inspira Technologies Oxy B.H.N. Ltd): פילוחים אנליטיים ודוחות לפי אינדיקטורים

EPS TTM measures the actual earnings per share by dividing the total annual net income by the volume of equity capital. This metric allows for the rapid monitoring of financial stability by neutralizing discrepancies between reporting standards. For Inspira Technologies (IINN), this calculation reflects the cost of the technological race for FDA approval. By analyzing the EPS trend over the last 12 months, an investor can see the impact of innovation costs. The indicator's dynamics determine the fair value of capital amid the struggle against the ventilator monopoly.